RBR-type E3 ubiquitin ligase RNF144A targets PARP1 for ubiquitin-dependent degradation and regulates PARP inhibitor sensitivity in breast cancer cells

Abstract excerpt

// Ye Zhang 1, * , Xiao-Hong Liao 1, 2, 3, * , Hong-Yan Xie 1, 2, 3 , Zhi-Min Shao 1, 2, 3, 4, 5 and Da-Qiang Li 1, 2, 3, 4, 5 1 Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China 2 Department of Oncology, Shanghai Cancer Center, Shanghai Medical College, Fudan University, Shanghai 200032, China 3 Cancer Institute, Shanghai Cancer...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CRISPR and Genetic Engineering
• Share to DNA Repair Mechanisms
• Share to PARP inhibition in cancer therapy